TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+13.64%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.46B
AUM Growth
+$2.46B
(+5.4%)
Cap. Flow
-$90.4M
Cap. Flow
% of AUM
-3.67%
Top 10 Holdings %
Top 10 Hldgs %
40.31%
Holding
213
New
10
Increased
47
Reduced
70
Closed
17
Top Buys
| 1 |
Pfizer
PFE
|
$23.5M |
| 2 |
Merck
MRK
|
$21.2M |
| 3 |
Welltower
WELL
|
$14.9M |
| 4 |
Eli Lilly
LLY
|
$10.2M |
| 5 |
CELG
Celgene Corp
CELG
|
$8.65M |
Top Sells
| 1 |
Biogen
BIIB
|
$19.1M |
| 2 |
Johnson & Johnson
JNJ
|
$18.8M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$16.3M |
| 4 |
AbbVie
ABBV
|
$13.9M |
| 5 |
Thermo Fisher Scientific
TMO
|
$13.5M |
Sector Composition
| 1 | Healthcare | 94.43% |
| 2 | Real Estate | 2.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Labcorp
LH
$22.8B
| $6.99M | 0.28% |
45,657
+16,557
| +57% | +$2.53M |
|
|
ABMD
77
DELISTED
Abiomed Inc
ABMD
| $6.85M | 0.28% |
23,986
+11,636
| +94% | +$3.32M |
|
78
Centene
CNC
$14.8B
| $6.81M | 0.28% |
128,295
-38,574
| -23% | -$10.9M |
|
|
LTC
79
LTC Properties
LTC
$1.67B
| $6.66M | 0.27% |
145,421
-33,202
| -19% | -$1.52M |
|
|
ICPT
80
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $6.63M | 0.27% |
59,275
+45,927
| +344% | +$5.14M |
|
81
CRISPR Therapeutics
CRSP
$4.82B
| $6.37M | 0.26% |
178,348
| – | – |
|
82
Cencora
COR
$57.2B
| $6.3M | 0.26% |
79,226
-32,581
| -29% | -$2.59M |
|
83
Ventas
VTR
$30.7B
| $6.29M | 0.26% |
98,496
| – | – |
|
84
Agios Pharmaceuticals
AGIO
$2.36B
| $6.19M | 0.25% |
91,776
+42,751
| +87% | +$2.88M |
|
85
Steris
STE
$23.9B
| $6.15M | 0.25% |
48,003
| – | – |
|
86
Medical Properties Trust
MPW
$2.66B
| $6.04M | 0.25% |
326,063
-87,746
| -21% | -$1.62M |
|
87
Quest Diagnostics
DGX
$20.1B
| $5.98M | 0.24% |
66,500
| – | – |
|
|
GWPH
88
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $5.88M | 0.24% |
34,891
-28,454
| -45% | -$4.8M |
|
|
DOC
89
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $5.72M | 0.23% |
303,908
-87,108
| -22% | -$1.64M |
|
90
Galapagos
GLPG
$2.06B
| $5.72M | 0.23% |
48,525
-51,290
| -51% | -$6.04M |
|
|
IMMU
91
DELISTED
Immunomedics Inc
IMMU
| $5.53M | 0.22% |
287,687
-143,840
| -33% | -$2.76M |
|
92
Ultragenyx Pharmaceutical
RARE
$3.04B
| $5.34M | 0.22% |
76,958
| – | – |
|
|
WCG
93
DELISTED
Wellcare Health Plans, Inc.
WCG
| $5.2M | 0.21% |
19,286
+6,286
| +48% | +$1.7M |
|
94
Acadia Healthcare
ACHC
$2.15B
| $5.08M | 0.21% |
173,155
| – | – |
|
|
ZGNX
95
DELISTED
Zogenix, Inc.
ZGNX
| $4.94M | 0.2% |
89,762
-21,263
| -19% | -$1.17M |
|
96
United Therapeutics
UTHR
$17.7B
| $4.84M | 0.2% |
41,261
| – | – |
|
97
AnaptysBio
ANAB
$630M
| $4.81M | 0.2% |
65,845
| – | – |
|
98
Merus
MRUS
$5.04B
| $4.69M | 0.19% |
317,671
-50,000
| -14% | -$739K |
|
|
GBT
99
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.55M | 0.18% |
85,988
-7,936
| -8% | -$420K |
|
100
Bio-Techne
TECH
$8.3B
| $4.31M | 0.18% |
+21,701
| New | +$4.31M |
|